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The different tomographic methods available in 
medical diagnostics and research deliver compre-
hensive structural and functional insights of the 
body. Whereas CT and MRI primarily produce 
high-resolution images of anatomical details, 
single photon emission CT (SPECT) and PET 
allow imaging of a wide variety of physiological 
and biochemical processes. Previously, patients 
had to be investigated sequentially by these meth-
ods to gather complementary diagnostic infor-
mation. The introduction of PET and CT in a 
single device provides corresponding functional 
and structural information in one examina-
tion [1]. Especially in oncology, the combination 
of CT with PET using [18F]-fluorodeoxyglucose 
has proved to be most successful [2–4]. As a con-
sequence, industry shows increasing interest in 
combining other tomographic devices in order 
to disclose new perspectives for research as well 
as clinical applications. SPECT/CT, originally 
suggested by Hasegawa [5] and nowadays offered 
by the majority of manufacturers, is becoming 
more and more popular [2,3,6]. Recently, the first 
prototypes of hybrid scanners allowing simul-
taneous MR-PET for brain studies have been 
developed and installed in two centers in both 
Germany and the USA. The combination of the 
outstanding diagnostic properties of MRI and 
PET enables a variety of totally novel multipara-
metric applications if both methods can be per-
formed simultaneously. Whereas PET/CT and 
SPECT/CT could be combined using existing 
technologies, the integration of PET within an 
MRI device demands a new detector technol-
ogy for PET. In this article the development of 
this new technology is explained, the technical 
features of MR-PET are described, the results of 
first applications in humans are presented and 
possible applications are indicated.
Towards PET integrated with ultra-high 
field MRI for small animal studies
The first experimental work that resulted in 
simultaneously acquired PET und MR images of 
a phantom was pioneered by the group of Cherry 
and Marsden at University of California, Los 
Angeles (UCLA; CA, USA) in 1997 [7]. To avoid 
interferences from the magnetic field of a 0.2 T 
open magnet MRI system onto the magneto-
sensitive PET electronics, they connected the 
scintillation crystals and the photomultiplier by 
4-m long optical fibers. If the PET detector of 
a MR-PET system utilizes the classical detector 
technology with photomultipliers, these elec-
tronic tubes must be kept away from the mag-
netic field. Furthermore, if only the scintillation 
crystals are in the MR field of view, interferences 
of the PET detector onto MRI are minimized. 
Consequently, more recent approaches kept the 
photomultiplier outside the magnetic field and 
coupled them to scintillation crystals by opti-
cal fibers of least 0.8 m [8–11]. A direct coupling 
without fibers became possible in the case of a 
field-cycled MR scanner [12]. Until now most of 
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these developments designed for small animal 
imaging are still ongoing and being tested for 
further optimization.
Since light loss along the fibers compromises 
the quality of PET imaging, solutions had to 
be found that allow very short fibers or a direct 
coupling between scintillation crystals and 
readout electronics located very near or in the 
magnetic field of conventional MR scanners. 
The fundamental solution was the replacement 
of photomultipliers by solid state components, 
such as Avalanche photodiodes (APDs) as first 
suggested by Pichler and coworkers in 1998 [13], 
and later realized by Pichler, Catana and 
coworkers in Cherry’s group at the University 
of California, Davis (CA, USA) [14,15]. Catana 
reported a PET detector where fibers of approx-
imately 15 cm in length coupled an 8 × 8 array 
of lutetium oxy orthosilicate (LSO) crystals 
to a position-sensitive APD [15]. This detec-
tor was placed in a Bruker 7-T Biospec animal 
MRI system. PET images of a mouse after 
injection of [18F]-fluoride could be recorded 
ex vivo simultaneously with MR images with-
out showing remarkable artefacts. In parallel, 
this approach has been and is being further 
developed by Pichler’s group at the University 
of Tübingen (Tübingen, Germany), which 
achieved a direct coupling between LSO 
crystals and an array of single APDs within a 
small animal 7-T MR scanner [16]. At different 
meetings and in initial publications this group 
reported successful hybrid MR-PET imaging 
in mice and rats [17,18].
Schlyer and coworkers at Brookhaven 
National Laboratories (NY, USA) [19] con-
structed a small APD-based detector ring 
known as ‘Rat Conscious Animal PET’ 
(RatCAP), which can be fixed around the neck 
and head of a rat in a way that the animal car-
ries the PET ring and can remain conscious. 
Using APDs to read out the LSO crystals the 
first RatCAP was already basically MR compat-
ible. After different modifications the PET ring 
can be operated within a 9.4 T MRI for small 
animals, which must, however, been anesthe-
tized. Recently, first studies after injection of 
the dopamine radioligand [11C]-raclopride in 
a rat could demonstrate the feasibility of the 
RatCAP-based approach [20]. 
First prototypes of a MR-PET scanner for 
human brain studies
In November 2006 the first PET and MR 
images simultaneously acquired in a human 
subject were presented at the meeting of 
the Radiological Society of North America 
(RSNA) [21]. These images were obtained with 
a new APD-based PET detector known as 
BrainPET and developed by Siemens (Munich, 
Germany) [22]. The BrainPET is operated 
within a standard Siemens 3T MAGNETOM 
Trio MR scanner (Figure 1). The basic design of 
the PET detector is similar to that of Pichler’s 
group. The front end of the detector module is 
a 12 × 12 matrix of 2.5 × 2.5 × 20 mm3 indi-
vidual LSO crystals coupled to a 3 × 3 array 
of APDs. Six detector modules are aligned in 
a copper-shielded cassette, 32 of which form 
the cylindrical PET detector, which has an 
outer diameter of 60 cm just fitting the MR 
bore. Two dedicated head coils for MR (one 
outer bird cage coil for combined transmit and 
receive, and one inner eight-channel coil for 
receive), which are both optimized in regard 
to minimal attenuation for PET, can be placed 
into the PET ring with an inner diameter of 
32 cm. The transmit/receive coil is necessary 
because the normal whole-body transmit coil 
of the MAGNETOM Trio is switched off in 
the 3TMR-BrainPET. Each of the 32 cas-
settes is linked by a 10-m long cable to the 
filter plate of the MRI cabin, on the exterior 
of which a modified version of the QuickSilver 
data acquisition electronics [23] is attached. The 
coincidence window of the BrainPET is 12 ns 
and the energy window ranges from 420 to 
580 keV. Since the APDs are very tempera-
ture dependent, the BrainPET’s temperature 
is stabilized with cooled air. Preliminary per-
formance tests confirmed the feasibility for 
simultaneous MR-PET imaging without severe 
interferences between the two modalities and 
some favorable performance parameters that 
are equal to or better than those of other pres-
ent PET detectors for human studies [24]. The 
central image resolution is approximately 
3 mm, which means the BrainPET together 
with the high-resolution research tomograph 
PET-only scanner [25] offers the best PET image 
resolution presently available for human brain 
studies. The count rate does not saturate at 
radioactivities applied for human studies and 
the (point source) sensitivity is approximately 
6%. Since the BrainPET is an insert of the MR 
scanner and not integrated within the MR gan-
try, it might even be operated alone. From 2006 
to 2010 a limited number of four prototypes 
of this 3TMR-BrainPET have been installed 
in two German laboratories at Tübingen and 
Jülich and in Boston and Atlanta, where they 
have been undergoing comprehensive tests. 
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First human studies with the 
3TMR-BrainPET in Jülich
The results obtained with the 3TMR-BrainPET 
to date, and reported at scientific meetings and in 
first publications, aim at examining the feasibility 
of the integrated MR-PET scanner by comparing 
images of BrainPET with that of conventional 
PET or PET/CT scanners. The primary aim of 
testing the 3TMR-BrainPET is to look at the 
performance of the newly designed PET detector 
operated in the specific environment of a mag-
netic field. The first tests of the 3TMR-BrainPET 
demonstrated that different MR sequences can 
be conducted simultaneously with the PET 
measurement without revealing obvious MR 
artefacts. Nevertheless, after the ongoing tests 
of the BrainPET the MR performance will be 
tested in more detail. 
In our laboratory the evaluation of the 3TMR-
BrainPET is primarily based on comparative stud-
ies of patients with malignant brain tumors who 
are primarily scanned in an ECAT Exact HR+- 
PET scanner for diagnostic purposes or for a clini-
cal research study, for example to look at thera-
peutic effects [26]. Since the 3TMR-BrainPET 
is not a commercial product but a prototype, it 
can only be applied for human studies under the 
conditions of a clinical study according to §20 
of the German Medical Devices Act. The stud-
ies were approved by the local ethical committee 
and written informed consent was obtained from 
each patient measured in the 3TMR-BrainPET.
The study with the HR+- PET was recorded 
for 50 min after the injection of approximately 
200 MBq [18F]-fluoroethyltyrosine (FET), an 
amino-acid tracer that is able to delineate the 
tumor better than MRI [27]. After this scan the 
patient may have been asked to volunteer for a 
further imaging procedure of 30–40 min in the 
3TMR-BrainPET. For this scan no additional 
FET needed to be injected, because the biological 
washout of FET out of the brain and tumor as 
well as the radioactive decay with a physical half-
life of 109 min are slow. Thus, the BrainPET 
images were compared with the results of the 
HR+ as demonstrated in Figure 2. The images 
of the two scanners are very similar. Small mis-
matches of the spatial distribution of FET can be 
explained by the fact that the radiotracer’s uptake 
is not stationary in normal brain and tumor, but 
changes in a different way. In order to achieve 
comparable count statistics, the summed HR+ 
image comprises 20 min, whereas the BrainPET 
image acquired later was summed over 30 min. 
Both PET images show the tumor clearly. The 
BrainPET images look less blurred than the HR+ 
images, indicating the better image resolution of 
the BrainPET. During the BrainPET scan shown 
in this article a number of MR sequences were 
recorded: T
1
-weighted magnetization-prepared 
rapid acquisition with gradient echo (MPRAGE) 
with and without contrast enhancement using 
gadolinium and T
2
-weighted turbo inversion 
recovery magnitude (Figure 3). These recordings, 
together with the initial localizer, took approxi-
mately 20 min so that there is ample time for 
additional sequences during the PET acquisition, 
as indicated later.
Since the PET images are not only analyzed 
qualitatively, but also quantitatively, for example 
by determining the tumor-to-brain ratio of FET 
uptake at a certain time after injection, the PET 
data must undergo several corrections. In con-
ventional PET and PET/CT, transmission scans 
are performed to measure a tissue attenuation 
map needed for attenuation correction. This is 
not possible in the 3TMR-BrainPET, because 
the spatial conditions do not allow the installa-
tion of a radiation source needed for transmission 
scans. Therefore, different solutions have been 
suggested and implemented to derive attenuation 
maps from the anatomic information offered by 
MRI [28–32]. In our group we have developed a 
template-based method [29] using a template of 
an MPRAGE image averaged from eight scans 
of different subjects, which were spatially nor-
malized [33] to one subject’s head shape and a 
corresponding template of an attenuation map 
obtained from transmission scans of these sub-
jects recorded with the HR+- PET (Figure 4). In 
addition, the MR coils must be included into the 
attenuation map [29,32]. Beside adequate attenua-
tion correction, further corrections for detector 
efficiency (normalization), radioactive decay, 
dead time and scatter, as well as calibration of 
Brain PET
3T MRI
Head coils
Phantom
Figure 1. The 3TMR-BrainPET as installed in 
the Forschungszentrum Jülich, Germany. 
The BrainPET is constructed as an insert into the 
MR bore. The MR head coils just fit into 
the BrainPET.
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the BrainPET, are essential to produce quantita-
tive images. The capability of the BrainPET to 
produce quantitative scans could be demonstrated 
in our laboratory in a number of patient studies 
by comparing BrainPET-based ratios of regions 
of interest of tumor and normal cortex and cor-
responding time–activity curves with those of the 
preceding HR+- scan. Thereafter, the protocol 
was changed in some patients who were placed 
first in the BrainPET so that dynamic measure-
ments in the MR-PET could be performed after 
tracer injection. An example of such a patient 
who was referred with a suspicion of a low-grade 
tumor is demonstrated in Figures 5 & 6. FET was 
injected intravenously into the patient lying in 
the 3TMR-BrainPET and a PET scan of 50 min 
was started, which delivered images on the FET 
kinetics similar to those observed with the HR+- 
scanner. After a short interval a complementary 
scan for 30 min was performed with the HR+- 
PET. During the BrainPET acquisition, simul-
taneous MRI was performed. In addition to the 
standard MR sequences, chemical shift imaging 
(CSI) was performed focused to the lesion visual-
ized by the MPRAGE image (Figure 5B), which was 
recorded directly after tracer injection. Figures 5A & 
6 display the BrainPET image summed from 20 
to 40 min after injection and the time–activity 
A B C D
Figure 3. PET simultaneous with versatile MRI. (A) While the patient already shown in Figure 2 
was investigated by [18F]-fluoroethyltyrosine-BrainPET, three MR sequences were performed: 
(B) T
1
-weighted magnetization-prepared rapid acquisition with gradient echo (MPRAGE) without 
contrast medium; (C) T
1
-weighted MPRAGE with contrast medium; and (D) T2-weighted turbo 
inversion recovery magnitude.
Figure 2. Transversal, coronal and sagittal images (from left to right) of a patient with a 
glioblastoma after surgery. The images on the top row were recorded with the BrainPET from 94 to 
124 min after injection of approxiamtely 200 MBq [18F]-fluoroethyltyrosine. The images on the bottom 
row were recorded with the HR+- PET and summed from 20 to 40 min after radiotracer injection.
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curves of regions of interest placed over the lesion 
and the normal cortex. Both the image and the 
time–activity curves show no differences between 
lesion and normal cortex so that the diagnosis of a 
high-grade tumor was unlikely. Conversely, CSI 
revealed an abnormal spectrum at the site of the 
lesion, which differed from that of the contralat-
eral normal tissue. A parametric map (Figure 5C) 
resulting from CSI presented an increased ratio 
of myo-inositol and N-acetyl-aspartate, which 
may also indicate an inflammatory process [34]. 
Thus, the simultaneous MR-PET study was able 
to deliver bimodal information about the lesion in 
a single imaging session of just 50 min.
The visual comparison of brain scans obtained 
with the BrainPET and the HR+- scanner 
demonstrates the superior image quality of the 
BrainPET and confirms the experimental data on 
image resolution given above. This finding is also 
underlined by a recent paper by Boss and cowork-
ers [35]. They compared brain tumor images 
recorded with a PET/CT first and thereafter with 
the BrainPET. Since the resolution of the images 
of the BrainPET superseded those of the PET/
CT, the authors smoothed the BrainPET’s images 
so that the partial volume effect became the same 
for both scanners and the final results matched.
In spite of these favorable results a critical 
inspection of both PET and MR images reveals 
some minor residual artifacts that need to be 
removed. The ongoing tests of the 3TMR-
BrainPET prototypes will try to find out for 
which applications these subtle problems are 
relevant or not and how they can be solved.
The near future of MR-PET
While the prototypes of the 3TMR-BrainPET 
are being tested, Siemens is developing a whole-
body 3TMR-PET hybrid scanner allowing for 
simultaneous bimodal imaging. Similar to the 
BrainPET, the PET detector is integrated within 
the MR scanner, however, not as a separate insert 
but outside the bore between the gradient and 
radiofrequency coils. The tests of first proto-
types are expected in late 2010. If the perfor-
mance of this novel scanner type is successful 
a commercial version can be expected, while at 
present there is no commitment of the manu-
facturer to produce a commercial version of the 
3TMR-BrainPET. This is owing to the fact that 
the market for specific brain scanners is regarded 
as limited. Whereas Siemens’ MR-PET systems 
are integrated scanners, Philips decided to com-
bine its standard 3TMR scanner Achieva with 
A B C D
A B C
D E
T T
Figure 4. Different steps of the template-based method to obtain a patient-specific 
attenuation map. (A) The 3TMR-BrainPET measurement delivers the PET data and (B) the 
magnetization-prepared rapid acquisition with gradient echo (MPRAGE) image of a patient. Using 
the Statistical Parametric Mapping (SPM) software [33] the matrix T describing the deformation from 
the MPRAGE template (D) to (B) is determined. Then T is applied to the attenuation template (E) 
resulting in the attenuation map (C) specific for the individual patient.
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the PET component of their PET/CT. In this 
hybrid scanner both components are remote from 
each other by approximately 3 m, but linked by a 
common patient bed. The system does not allow 
for simultaneous imaging, but helps to minimize 
or even avoid misalignments between MR and 
PET, because the patient does not need to change 
their beds, keeping his position from one scan to 
the other. By combining standard MR and PET 
components and keeping the PET away from the 
magnetic field (a residual magnetic field is taken 
into account by appropriate shielding) Philips 
avoided the intrinsic problems of an integrated 
MR-PET. Although this hybrid scanner will not 
allow simultaneous MR-PET imaging, it may 
deliver valuable data on the performance of whole-
body MR-PET in comparison with PET/CT in 
cancer diagnostics [36]. Furthermore, Philips is 
exploring the field of simultaneous MR-PET 
under the EU FP7 project HYPERImage [101]. 
The goal of this project is the joint development, 
with various academic and industrial partners, of 
a new compact digital MR-compatible TOF-PET 
detector technology, which will be first tested in 
a prototype of a preclinical scanner for rabbits 
and mice. There is no commitment by Philips 
regarding a commercial product, neither for small 
animal nor human studies.
The necessity of MR-PET allowing simultane-
ous acquisition of both modalities remains a mat-
ter of discussion [37–41]. For the brain, anatomical 
coregistration is quite reliable and functional PET 
images can conveniently be registered to anatomi-
cal MR images using one of the many fusion pro-
grams available from academics and industry. From 
this point of view one may not need a simultaneous 
MR-PET recording. On the other hand, in our 
experience multiparameter imaging with different 
devices is extremely time consuming and stress-
ful to the patients, and the reduction of scanner 
times is an important point in patient care. This 
applies especially for cancer patients and patients 
with severe neurological disorders. Furthermore, 
the economic advantage of a more efficient patient 
throughput needs to be considered. 
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Figure 6. Quantitative [18F]-fluoroethyltyrosine kinetics recorded with the 
3TMR-BrainPET. Time–activity curves of [18F]-fluoroethyltyrosine kinetics in the 
patient shown in Figure 5. There is practically no difference between the curves of 
normal brain and the lesion, indicating that the lesion visible in the magnetization-
prepared rapid acquisition with gradient echo (MPRAGE) image (Figure 5B) is 
unlikely to be caused by a high-grade tumor.
A B C
INS/
NAA
Figure 5. [18F]-fluoroethyltyrosine-PET and MPRAGE image of a patient referred with a 
suspicion of a low grade tumor. (A) [18F]-fluoroethyltyrosine-PET revealed no radiotracer uptake at 
the lesion (cross) visible in (B) the magnetization-prepared rapid acquisition with gradient echo 
(MPRAGE) image. (C) After the MPRAGE image, chemical shift imaging was recorded while the PET 
measurement was still ongoing. Chemical shift imaging showed an increased ratio of myo-inositol 
and N-acetyl-aspartate, indicating the possible involvement of an inflammatory process.
INS: Myo-inositol; NAA: N-acetyl-aspartate.
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In brain research a combined MR-PET offers 
many perspectives beyond the common combi-
nation of functional PET and anatomical MRI. 
Considering the capabilities of physiological and 
biochemical MRI, a variety of research investi-
gations can be foreseen in which the functional 
capabilities of both MRI and PET may be used 
in a complementary way [42]. For example, the 
reaction of the brain to pharmacological chal-
lenges or mental stimulation may be observed 
by neuroreceptor studies in parallel with func-
tional activation by functional MRI. Another 
example, which may even be of clinical relevance 
for cerebrovascular diseases, is the combined 
measurement of brain perfusion by diffusion-
weighted imaging and of oxygen consumption 
by [15O]–oxygen–PET.
Thus, there is no simple yes/no answer regard-
ing whether to choose separate, combined or 
even integrated MR-PET. In the near future, 
different systems will be examined yielding ver-
satile experience and probably new applications 
in both brain research and clinics.
Conclusion & future perspective
The present results with first MR-PET proto-
types demonstrate the feasibility of this new 
hybrid imaging technology and have led to an 
increasing interest of both researchers and clini-
cians. Although industrial MR-PET scanners 
produced in the near future will be constructed 
primarily for whole-body imaging, they will 
allow the development of new bimodal neuroim-
aging procedures. After further methodologi-
cal developments, one may expect that reliable 
quantitative PET imaging will be possible with 
MR-PET. When reflecting whether MR-PET 
will have a similar success as PET/CT one must 
also consider that the soft tissue contrast of MRI 
is superior to CT and that MRI causes no radi-
ation dose. Furthermore, MR-PET inherently 
possesses many degrees of freedom for future 
research and clinical applications by combin-
ing the specific capabilities of PET and MRI. 
However, the success of a new method is not 
independent of economic variables.
Executive summary
Towards PET integrated with ultra-high MRI for small animal studies
n For MR-PET in small animals different designs have been suggested based on either conventional PET technology or MR-insensitive 
solid-state electronics.
n The first applications demonstrate the potential of MR-PET in preclinical research.
First prototypes of a MR-PET scanner for human brain studies
n In the BrainPET’s detectors photomultipliers are replaced by Avalanche photodiodes.
n The two imaging modalities of the 3TMR-BrainPET show no remarkable interferences.
First results obtained with 3TMR-BrainPET
n The 3TMR-BrainPET allows PET simultaneously recorded with different MR sequences.
n The BrainPET offers an excellent image resolution. 
n Bimodal imaging with an integrated MR-PET system increases patient’s compliance. 
The near future of MR-PET
n Experience with four prototypes is strongly considered in the ongoing development of whole-body MR-PET.
n The combination of MRI and PET in one scanner leads to new horizons of multiparametric functional neuroimaging.
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